Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

SHE:002693 Revenue

Hainan Shuangcheng Pharmaceuticals had revenue of 84.78M CNY in the quarter ending September 30, 2025, with 164.39% growth. This brings the company's revenue in the last twelve months to 216.15M, up 19.66% year-over-year. In the year 2024, Hainan Shuangcheng Pharmaceuticals had annual revenue of 174.21M, down -26.16%.

• Revenue (ttm): 216.15M
• Revenue Growth: +19.66%
• P/S Ratio: 15.14
• Revenue / Employee: 357.27K
• Employees: 605
• Market Cap: 3.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	174.21M	-61.72M	-26.16%
Dec 31, 2023	235.93M	-38.82M	-14.13%
Jan 1, 2023	274.75M	-45.54M	-14.22%
Jan 1, 2022	320.29M	50.85M	18.87%
Dec 31, 2020	269.44M	-77.21M	-22.27%